このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Pregnancy With Insomnia: a Trial of Acupuncture (GAS)

2017年6月27日 更新者:Assistance Publique - Hôpitaux de Paris

Acupuncture is widely used for treatment of insomnia. The research hypothesis is that acupuncture may be more effective than sham acupuncture to treat insomnia during pregnancy.

GAS is a randomized controlled trial with placebo acupuncture using the insomnia severity index (ISI) as the main outcome criterion.

調査の概要

状態

わからない

条件

詳細な説明

Scientific justification:

- During pregnancy, insomnia occurs mainly in women without a previous history of sleep disorder, and may remain after delivery. Insomnia affects the quality of life. It might be associated with an increase in labor duration and cesarean section rate.

Insomnia tends to worsen during gestation, owing to back pain, an increased need to micturate, and the movement of the fetus. Sleep disorders are often associated with restless legs syndrome.

  • To treat insomnia during pregnancy, the Haute Autorité de Santé (HAS) recommends avoiding using psychotropic medications. It also recommends screening for depression or anxiety traits often associated with insomnia. However, in most cases, psychological means alone fail to treat insomnia effectively.
  • Based on 11 randomized controlled trials, the odds of improving sleep disorders are 3 times greater with than without acupuncture, but the methodological quality of these trials is considered insufficient to conclude.

Population:

The study focused on pregnant women suffering from insomnia, excluding women with pregnancies complicated by pre-eclampsia, fetal growth anomalies, or threatened premature labor for fear those complications might interact with sleep disorders, as well as women with known psychiatric disorders. We also excluded women with a history of insomnia before pregnancy to focus on insomnia triggered by pregnancy only.

Objectives:

  • Primary objective: To assess the effect of a standardized acupuncture protocol vs. placebo on insomnia during pregnancy.
  • Secondary objectives: To assess the effect of a standardized acupuncture protocol vs. placebo on (i) the Pittsburgh Sleep Quality Index (PSQI), (ii) anxiety and depression traits, (iii) use of psychotropic medicines and (iv) recreational substances, (v) the incidence of restless legs syndrome, (vi) perinatal outcome .

Study design:

  • Study Type: Multicentre, Interventional, randomized, 2 parallel groups
  • Endpoint Classification: Efficacy Study
  • Intervention Model: Parallel Assignment
  • Masking: Single blind (patient blinded to intervention)
  • Primary Purpose: Treatment
  • One acupuncture session weekly for 4 consecutive weeks

Visits:

  • Selection: When a pregnant woman complains from insomnia, the health professional in charge will fill a checklist of inclusion and exclusion criteria, provide the patient with a pre inclusion ISI questionnaire and give the patient an information sheet and a copy of the consent. When a pregnant woman is sent to the acupuncturist for sleep disorders, he or she may proceed to the selection visit.
  • Inclusion: The acupuncturist checks for inclusion and exclusion criteria, collects the patient written consent, performs the clinical examination, gives the corresponding self-assessment questionnaires and proceeds to computerized randomization.
  • Follow-up: At visits 1 to 4, the acupuncturist performs the treatment, and records side effects if any. Visits are scheduled on a weekly basis.
  • End of research: At visit 5 (one week after last acupuncture session), the acupuncturist gives the corresponding self-assessment questionnaires.

研究の種類

介入

入学 (予想される)

60

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年歳以上 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

女性

説明

Inclusion Criteria:

  • Age > 18 years
  • Singleton pregnancy
  • Gestational age ≥ 16 weeks + 0 day and ≤ 32 weeks + 6 days
  • Insomnia Severity Index ≥ 10
  • Insomnia reported to have started during pregnancy and at least 2 weeks before inclusion
  • Patient understanding the study
  • Informed consent signed
  • Social insurance available at inclusion and until the end of pregnancy

Exclusion Criteria:

  • Threatened premature labor
  • Small fetus for gestational age
  • Pre-eclampsia
  • Insomnia starting before pregnancy
  • Use of psychotropic drugs before pregnancy
  • Use of recreational drugs during pregnancy
  • Known psychiatric disorder
  • Anticoagulant therapy
  • Patient reporting insomnia results from chronic or acute pain
  • Obstructive sleep apnea (OSA) requiring treatment
  • Patient under antidepressant therapy
  • Patient under legal guardianship or deprived of freedom

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:独身

武器と介入

参加者グループ / アーム
介入・治療
実験的:Regular acupuncture needles
Real acupuncture procedure The real acupuncture will be performed by means of standard stainless-steel needles (0.30-mm diameter, 30-mm length/Gauge 8 x 1.2"), located bilaterally in 5 real acupoints.
The patient will be in a semi recumbent position during needle penetration. Duration of needle insertion: 30 minutes
偽コンパレータ:Sham acupuncture needles
Sham acupuncture with a no penetrating sham needle (blunt and telescopic), giving the impression of insertion but without penetrating the skin will be placed bilaterally in 5 false acupoints
The patient will be in a semi recumbent position during needle penetration. Duration of needle insertion: 30 minutes

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Insomnia severity index (ISI)
時間枠:Inclusion visit and 5 weeks after the first acupuncture session
Difference of ISI self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session
Inclusion visit and 5 weeks after the first acupuncture session

二次結果の測定

結果測定
メジャーの説明
時間枠
Pittsburgh Sleep Quality Index (PSQI)
時間枠:Inclusion visit and 5 weeks after the first acupuncture session
Difference of PSQI self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session
Inclusion visit and 5 weeks after the first acupuncture session
Hospital Anxiety and Depression Scale (HADS)
時間枠:Inclusion visit and 5 weeks after the first acupuncture session
Difference of HADS self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session
Inclusion visit and 5 weeks after the first acupuncture session
Cumulated dose of each psychotropic medicine
時間枠:Inclusion visit and 5 weeks after the first acupuncture session
During the study period, the patients will note on a logbook the daily use of any drug.
Inclusion visit and 5 weeks after the first acupuncture session
Cumulated dose of alcohol
時間枠:Inclusion visit and 5 weeks after the first acupuncture session
During the study period, the patients will note on a logbook the daily use of alcohol.
Inclusion visit and 5 weeks after the first acupuncture session
Cumulated dose of tobacco
時間枠:Inclusion visit and 5 weeks after the first acupuncture session
During the study period, the patients will note on a logbook the daily use of tobacco.
Inclusion visit and 5 weeks after the first acupuncture session
Cumulated dose of cannabis
時間枠:Inclusion visit and 5 weeks after the first acupuncture session
During the study period, the patients will note on a logbook the daily use of cannabis.
Inclusion visit and 5 weeks after the first acupuncture session
Cumulated dose of other recreational substances or medicine
時間枠:Inclusion visit and 5 weeks after the first acupuncture session
During the study period, the patients will note on a logbook the daily use of other recreational substances and medicine.
Inclusion visit and 5 weeks after the first acupuncture session
Difference in the frequency of restless leg syndrome
時間枠:Inclusion visit and 5 weeks after the first acupuncture session

According to the guidelines of the International Restless Legs Syndrome Study Group.

The diagnosis of restless leg will rely on the presence of all of the following criteria:

  1. Desire to move the extremities usually associated with discomfort or disagreeable sensations in the extremities.
  2. Motor Restlessness-patients move to relieve the discomfort, for example walking, or to provide a counter-stimulus to relieve the discomfort, for example, rubbing the legs.
  3. Symptoms are worse at rest with at least temporary relief by activity.
  4. Symptoms are worse later in the day or at night.
Inclusion visit and 5 weeks after the first acupuncture session
Perinatal outcome - Gestational age at birth
時間枠:At birth
The gestational age at birth of the newborn will be recorded.
At birth
Perinatal outcome - birth weight
時間枠:At birth
The weight (in gr) at birth of the newborn will be recorded.
At birth
Perinatal outcome - birth height
時間枠:At birth
The height (in cm) at birth of the newborn will be recorded.
At birth
Perinatal outcome - sex
時間枠:At birth
The sex of the newborn will be recorded.
At birth
Perinatal outcome - perinatal mortality
時間枠:At birth
The perinatal mortality will be recorded.
At birth
Perinatal outcome - five minutes Apgar score
時間枠:At birth
The five minutes Apgar score will be recorded.
At birth
Perinatal outcome - cesarean section rate
時間枠:At birth.
Cesarean section rate will be recorded.
At birth.

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

捜査官

  • 主任研究者:Stéphanie Nicolian, Midewife、Assistance Publique - Hôpitaux de Paris

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (予想される)

2017年9月1日

一次修了 (予想される)

2019年1月1日

研究の完了 (予想される)

2019年5月1日

試験登録日

最初に提出

2017年5月23日

QC基準を満たした最初の提出物

2017年6月19日

最初の投稿 (実際)

2017年6月21日

学習記録の更新

投稿された最後の更新 (実際)

2017年6月28日

QC基準を満たした最後の更新が送信されました

2017年6月27日

最終確認日

2017年4月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

米国で製造され、米国から輸出された製品。

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

Acupuncture needlesの臨床試験

購読する